Drugs / Lactobacillus rhamnosus strain GG ATCC 53103
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT00490425 | Oct 2002 → Oct 2006 | allergic asthma | Johann Wolfgang Goethe University Hospital | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Lactobacillus rhamnosus strain GG ATCC 53103 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00490425 ↗ |
| Known as | LGG | “Our prospective double-blind study randomly assigned 131 children (6-24 months old) with at least two wheezing episodes and a first-degree family history of atopic disease to 6...” PMID 20604800 ↗ Jun 2010 |
| Modality | Other / unclassified | “Efficacy of probiotic Lactobacillus GG on allergic sensitization and asthma in infants at risk.” PMID 20604800 ↗ Jun 2010 |
| Route | Oral | “oral LGG had no clinical effect on atopic dermatitis or asthma-related events” PMID 20604800 ↗ Jun 2010 |